Cargando…

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway

PURPOSE: Berbamine (Ber), a bioactive constituent extracted from a traditional Chinese medicinal herb, has been shown to exhibit broad inhibitory activity on a panel of cancer cell types. However, its effects and the underlying molecular mechanisms on gastric cancer (GC) remain poorly understood. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongchun, Luo, Kexue, Yang, Zhuying, Chen, Miao, Yang, Xiuyun, Wang, Jiesheng, Ying, Yin, Wu, Dengxuan, Wang, Qinxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762520/ https://www.ncbi.nlm.nih.gov/pubmed/35046638 http://dx.doi.org/10.2147/DDDT.S338881

Ejemplares similares

Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells
por: Li, Hongchun, et al.
Publicado: (2020)

Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells
por: Hu, Bingren, et al.
Publicado: (2019)

Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis
por: Han, Chenglin, et al.
Publicado: (2021)

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
por: Li, Gong-Quan, et al.
Publicado: (2015)

Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”
por: Han, Chenglin, et al.
Publicado: (2021)

Berbamine, a bioactive alkaloid, suppresses equine herpesvirus type 1 in vitro and in vivo
por: Li, Zeyu, et al.
Publicado: (2023)

The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
por: Pang, Yingxin, et al.
Publicado: (2022)

MYC protein stability is negatively regulated by BRD4
por: Devaiah, Ballachanda N., et al.
Publicado: (2020)

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
por: Wang, Shan, et al.
Publicado: (2009)

Transcriptional regulation of BRD7 expression by Sp1 and c-Myc
por: Liu, Huaying, et al.
Publicado: (2008)

Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice
por: Chen, Chang-lan, et al.
Publicado: (2022)

Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer
por: Shen, Hao, et al.
Publicado: (2022)

Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
por: Yi, Dongrong, et al.
Publicado: (2022)

BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer
por: Zhao, Ran, et al.
Publicado: (2021)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

Comparative Transcriptomics for Genes Related to Berberine and Berbamine Biosynthesis in Berberidaceae
por: Roy, Neha Samir, et al.
Publicado: (2022)

An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
por: Ma, Liya, et al.
Publicado: (2022)

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
por: Venkataraman, Sujatha, et al.
Publicado: (2014)

Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer
por: Zhang, Hong, et al.
Publicado: (2020)

The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption
por: Zhang, Chongjing, et al.
Publicado: (2022)

Berbamine Hydrochloride Inhibits African Swine Fever Virus Infection In Vitro
por: Zhu, Junhai, et al.
Publicado: (2022)

BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma
por: Wang, Limei, et al.
Publicado: (2017)

Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy
por: Zheng, Yanjun, et al.
Publicado: (2017)

Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade
por: Cloherty, Alexandra P. M., et al.
Publicado: (2023)

circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex
por: Xie, Fei, et al.
Publicado: (2020)

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
por: Yin, Mingzhu, et al.
Publicado: (2020)

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss
por: Qi, Guobin, et al.
Publicado: (2022)

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression
por: Hong, Zhe, et al.
Publicado: (2023)

Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca(2+) axis
por: Zhang, Su, et al.
Publicado: (2023)

Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression
por: Tan, Yifan, et al.
Publicado: (2018)

In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma
por: Zhu, Hongmei, et al.
Publicado: (2018)

Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells
por: Jia, Feng, et al.
Publicado: (2017)

Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo
por: Parhi, Priyambada, et al.
Publicado: (2017)

Berbamine Reduces Chloroquine-Induced Itch in Mice through Inhibition of MrgprX1
por: Ryu, Kunhi, et al.
Publicado: (2022)

A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3
por: Fu, Ruoqiu, et al.
Publicado: (2018)

Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism
por: Lu, Huasong, et al.
Publicado: (2015)

2-methylbenzoyl berbamine, a multi-targeted inhibitor, suppresses the growth of human osteosarcoma through disabling NF-κB, ERK and AKT signaling networks
por: Li, Weixu, et al.
Publicado: (2020)

DSC2 Suppresses the Metastasis of Gastric Cancer through Inhibiting the BRD4/Snail Signaling Pathway and the Transcriptional Activity of β-Catenin
por: Sun, Chao, et al.
Publicado: (2022)

Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
por: Fiorentino, Francesco Paolo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4m806m30m8oqm7upcobko2kcjl